Lupus Foundation of America : Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Lupus Foundation of America Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis
News provided by
Share this article
Share this article
WASHINGTON, Dec. 17, 2020 /PRNewswire/ The U.S. Food and Drug Administration (FDA) has approved Benlysta to treat lupus nephritis (lupus-related kidney disease) in adults. The approval is for both the intravenous and subcutaneous formulations. The decision makes Benlysta the first lupus therapy authorized to treat this potentially life-threatening complication of the disease. Up to 60 percent of people with lupus will develop lupus nephritis.
Benlysta is a human monoclonal antibody sold by GSK. The FDA first approved Benlysta for lupus in 2011. However, at that time, Benlysta had not been studied for use in individuals with severe lupus nephritis.
Conference Meets the Moment as Global Crisis Highlights Homeschooling
December 15, 2020
As policymakers around the world grapple with how to defeat COVID-19 and return their societies to some semblance of normality, one thing is certain homeschooling will continue to figure prominently in how children are educated.
In fact, the rise of homeschooling in response to the global pandemic and what this means to the future of education served as the focus of a recent conference held by the Global Home Education Exchange (GHEX).
Originally scheduled as an in-person event in the Philippines, like so many of this year’s activities, the conference was repackaged as an online offering.
A Changed Retail Environment Yields New Investor Opportunities There are still many avenues available for investors in retail properties looking for returns, safety, management ease or a combination of all of the above.
Tom Hershey | Dec 14, 2020
The pandemic has hastened the demise of many retailers but has been far from the sole ailment. Retailers have been struggling to contend with e-commerce for years, and for many, the pandemic was simply the final knell. Men’s Wearhouse, Neiman Marcus, JC Penney, Lord & Taylor, and Ann Taylor have all entered bankruptcy, hammered by more than a 20 percent decline in clothing sales year over year. There are, however, retailers that have survived and even prospered, and keen-eyed investors are taking note.